Colgate-PalmoliveNYSE: CL

Colgate is gaining from strong pricing and productivity efforts. The company's approach to innovation is also promising.

Colgate-Palmolive (CL) is likely to do better than the market because it shows stronger financial growth compared to others.

Jim Cramer from CNBC shares his reasons for monitoring Colgate-Palmolive's stock closely. He believes there are important factors to consider regarding the company's performance. Cramer thinks it could be a significant investment opportunity.

Colgate-Palmolive Company's earnings for the third quarter had mixed outcomes, as revenue and earnings per share exceeded expectations, but sales in North America and Latin America fell, causing a 3% drop in stock prices. While the company has improved its gross margins and increased advertising spending, there are still worries about declining sales in certain regions. However, the Pet Nutrition segment is growing strongly, thanks to the trend of treating pets more like family, which could significantly boost revenue.

CL's Q3 results show ongoing improvements in both volume and pricing, resulting in organic sales growth in five out of six divisions. Better margins also contribute to the increase in earnings per share (EPS).

Colgate-Palmolive Company (NYSE:CL) will hold its Q3 2024 Earnings Conference Call on October 25, 2024, at 8:30 AM ET. The call will feature key company leaders, including John Faucher, the Chief Investor Relations Officer, and Noel Wallace, the President and CEO. Various analysts from major financial institutions will also participate in the discussion.

The financial results for Colgate-Palmolive (CL) from the quarter ending in September 2024 provide insight into the company's performance. It may also be helpful to compare some important figures with Wall Street predictions and the same period from the previous year.

Colgate-Palmolive Co (NYSE:CL) has increased its lower forecast for 2024 after a successful third quarter. The company's revenue for Q3 reached $5.03 billion, surpassing the expected $5.01 billion, and its earnings per share (EPS) of $0.91 exceeded the predicted $0.88.

Colgate-Palmolive (CL) reported quarterly earnings of $0.91 per share, which is higher than the Zacks Consensus Estimate of $0.88 per share. This is an increase compared to last year's earnings of $0.86 per share.